562 related articles for article (PubMed ID: 10421878)
1. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
2. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
3. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
5. Molecular forms of acetylcholinesterases in Alzheimer's disease.
Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
[TBL] [Abstract][Full Text] [Related]
6. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
7. [Neuropathology of Alzheimer's disease and mild cognitive impairment].
López OL; DeKosky ST
Rev Neurol; 2003 Jul 16-31; 37(2):155-63. PubMed ID: 12938076
[TBL] [Abstract][Full Text] [Related]
8. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
9. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.
Ikonomovic MD; Mufson EJ; Wuu J; Bennett DA; DeKosky ST
Arch Neurol; 2005 Mar; 62(3):425-30. PubMed ID: 15767507
[TBL] [Abstract][Full Text] [Related]
10. Brain vesicular acetylcholine transporter in human users of drugs of abuse.
Siegal D; Erickson J; Varoqui H; Ang L; Kalasinsky KS; Peretti FJ; Aiken SS; Wickham DJ; Kish SJ
Synapse; 2004 Jun; 52(4):223-32. PubMed ID: 15103689
[TBL] [Abstract][Full Text] [Related]
11. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems.
Arvidsson U; Riedl M; Elde R; Meister B
J Comp Neurol; 1997 Feb; 378(4):454-67. PubMed ID: 9034903
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of cholinergic neurons in the rat superior olivary complex.
Yao W; Godfrey DA
Microsc Res Tech; 1998 May; 41(3):270-83. PubMed ID: 9605344
[TBL] [Abstract][Full Text] [Related]
13. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
[TBL] [Abstract][Full Text] [Related]
14. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.
Ikonomovic MD; Abrahamson EE; Isanski BA; Wuu J; Mufson EJ; DeKosky ST
Arch Neurol; 2007 Sep; 64(9):1312-7. PubMed ID: 17846271
[TBL] [Abstract][Full Text] [Related]
15. Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry.
Ichikawa T; Ajiki K; Matsuura J; Misawa H
J Chem Neuroanat; 1997 Jun; 13(1):23-39. PubMed ID: 9271193
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
[TBL] [Abstract][Full Text] [Related]
18. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
Chan-Palay V
J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
[TBL] [Abstract][Full Text] [Related]
19. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
[TBL] [Abstract][Full Text] [Related]
20. Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus.
Dubelaar EJ; Mufson EJ; ter Meulen WG; Van Heerikhuize JJ; Verwer RW; Swaab DF
J Neuropathol Exp Neurol; 2006 Mar; 65(3):257-66. PubMed ID: 16651887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
